NCI Will Participate in RFA-AR-12-007, "Ancillary Domain Development Patient-Reported Outcomes Measurement Information System (PROMIS ) Studies (R01)."

Notice Number: NOT-CA-12-011

Release Date: February 8, 2012

National Cancer Institute (NCI)

The purpose of this Notice is to inform potential applicants that NCI is participating in RFA-AR-12-007, "Ancillary Domain Development Patient-Reported Outcomes Measurement Information System (PROMIS ) Studies (R01)."

Catalog of Federal Domestic Assistance Number

93.393, 93.394, 93.395, and 93.399

Components of Participating Organizations

The Components of Participating Organizations section of RFA-AR-12-007 (R01) have been revised to include NCI:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Cancer Institute (NCI)

All other aspects of this FOA remain unchanged.

Please direct all inquiries to:

Scientific/Research Contact(s)

Ashley Wilder Smith, Ph.D., M.P.H
Behavioral Scientist and Program Director
Outcomes Research Branch
Applied Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 4090, MSC 7344
Bethesda, MD 20892-7344
Telephone: (301) 451-1843
Fax: (301) 435-3710
Email: [email protected]

Financial/Grants Management Contact

Crystal Wolfrey
National Cancer Institute
Office of Grants Administration
6120 Executive Boulevard, EPS Room 243
Bethesda, MD 20892-7150 (for U.S. Postal Service regular or express mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-496-8634
E-mail: [email protected]